We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Cooper Companies
COO
$14.2B
| $18.9M | 0.04% |
379,056
+18,936
| +5% | +$900K |
|
427
Globe Life
GL
$14B
| $18.9M | 0.04% |
245,006
+18,134
| +8% | +$1.38M |
|
|
VAL
428
DELISTED
Valspar
VAL
| $18.8M | 0.04% |
169,176
+6,172
| +4% | +$678K |
|
429
UDR
UDR
$12.8B
| $18.5M | 0.04% |
510,276
+31,817
| +7% | +$1.14M |
|
430
Pentair
PNR
$10.6B
| $18.4M | 0.04% |
437,282
+6,161
| +1% | +$246K |
|
431
Tractor Supply
TSCO
$16.3B
| $18.4M | 0.04% |
1,335,215
+62,155
| +5% | +$905K |
|
432
Cadence Design Systems
CDNS
$91.6B
| $18.4M | 0.04% |
585,718
+13,479
| +2% | +$393K |
|
433
Ingredion
INGR
$6.42B
| $18.4M | 0.04% |
152,658
+4,657
| +3% | +$570K |
|
434
Macerich
MAC
$7.4B
| $18.4M | 0.04% |
285,151
+16,801
| +6% | +$1.13M |
|
435
Synopsys
SNPS
$71.6B
| $18.3M | 0.04% |
253,988
-35,869
| -12% | -$2.4M |
|
436
Lennar Class A
LEN
$20.4B
| $18.2M | 0.04% |
374,327
+17,273
| +5% | +$783K |
|
|
CSC
437
DELISTED
Computer Sciences
CSC
| $18.2M | 0.04% |
263,306
+8,711
| +3% | +$578K |
|
438
Domino's
DPZ
$11.9B
| $18.2M | 0.04% |
98,541
+3,596
| +4% | +$644K |
|
439
Huntington Ingalls Industries
HII
$11B
| $18.1M | 0.04% |
90,572
+2,553
| +3% | +$519K |
|
|
TSS
440
DELISTED
Total System Services, Inc.
TSS
| $18.1M | 0.04% |
337,830
+17,386
| +5% | +$927K |
|
441
Iron Mountain
IRM
$35.9B
| $18.1M | 0.04% |
506,026
+25,838
| +5% | +$915K |
|
442
The Mosaic Company
MOS
$7.19B
| $18M | 0.04% |
617,753
+22,340
| +4% | +$690K |
|
443
MSCI
MSCI
$42.4B
| $18M | 0.04% |
185,120
+2,221
| +1% | +$201K |
|
444
Pinnacle West Capital
PNW
$12.4B
| $17.8M | 0.04% |
213,982
+9,899
| +5% | +$791K |
|
445
Kimco Realty
KIM
$17.5B
| $17.8M | 0.04% |
806,156
+47,743
| +6% | +$1.15M |
|
446
Alexandria Real Estate Equities
ARE
$9.37B
| $17.6M | 0.04% |
159,331
-5,569
| -3% | -$629K |
|
447
Fortune Brands Innovations
FBIN
$5.86B
| $17.6M | 0.04% |
337,447
+12,791
| +4% | +$627K |
|
448
Xylem
XYL
$28.5B
| $17.4M | 0.04% |
347,306
+5,943
| +2% | +$290K |
|
449
Regency Centers
REG
$14.9B
| $17.4M | 0.04% |
261,714
+53,178
| +26% | +$3.64M |
|
450
FMC
FMC
$1.25B
| $17.4M | 0.04% |
287,744
+6,790
| +2% | +$351K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.